Drugmaker to resolve opioid treatment marketing claims for $600 million
Share!
Business Insurance - Jul 24, 2020
Indivior PLC on Friday said it had agreed to pay $600 million and have a subsidiary plead guilty to a criminal charge to resolve U.S. allegations that it engaged in an illegal scheme to boost prescriptions of its opioid addiction treatment Suboxone....
Recommended Articles